Article
Progress and prospects of gene therapy clinical trials for the muscular dystrophies
8 Oct 2015
Abstract excerpt
Clinical trials represent a critical avenue for new treatment development, where early phases (I, I/II) are designed to test safety and effectiveness of new therapeutics or diagnostic indicators. A number of recent advances have spurred renewed optimism toward initiating clinical trials and developing refined therapies for the muscular dystrophies (MD's) and other myogenic disorders. MD's encompass a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
